Search

Your search keyword '"Yadav, Pragya D"' showing total 622 results

Search Constraints

Start Over You searched for: Author "Yadav, Pragya D" Remove constraint Author: "Yadav, Pragya D"
622 results on '"Yadav, Pragya D"'

Search Results

51. Canine Distemper Virus in Asiatic Lions of Gujarat State, India

53. A fatal case of Crimean‐Congo hemorrhagic fever from Kutch, Gujarat, India 2023.

54. Assessment of antibody kinetics in mpox cases with indigenously developed IgM and IgG ELISA.

55. A case of human buffalopox in Malappuram, India: The role of mpox surveillance in 2022

56. Needle‐free injection system delivery of ZyCoV‐D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS‐CoV‐2

57. To Test or Not to Test? A Cost-Effectiveness Analysis of Covid Rapid Diagnostic Tests for Severe/Critical Patients in Low-and-Middle Income Countries

59. Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage

60. Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months

61. Community transmission of SARS-CoV-2 with B.1.1.7 lineage in Mumbai, India

62. Crimean-Congo hemorrhagic fever in migrant worker returning from Oman to India, 2016

63. Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern

64. Clinical presentation, viral kinetics, and management of human monkeypox cases from New Delhi, India 2022

65. Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India

66. First two cases of Monkeypox virus infection in travellers returned from UAE to India, July 2022

69. Genomic profile of SARS-CoV-2 Omicron variant and its correlation with disease severity in Rajasthan

70. Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage

71. A fatal case of monkeypox virus infection from Kerala India 2022

72. Enterovirus Coxsackie A16 Detected in Hand, Foot, and Mouth Disease Outbreak Among Children in Western Uttar Pradesh, India, May to June 2022.

73. Acute Encephalitis with Atypical Presentation of Rubella in Family Cluster, India

76. A case control investigation of COVID-19 associated Mucormycosis in India

77. Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021

80. Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination

81. Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (CovishieldTM) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021

82. Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model

83. Zika a Vector Borne Disease Detected in Newer States of India Amidst the COVID-19 Pandemic

84. Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees

85. Serosurvey for Nipah virus in bat population of southern part of India

87. Host immune responses in aged rhesus macaques against BBV152, an inactivated SARSCoV-2 vaccine, and crossneutralization with beta and delta variants.

89. Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern

90. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model

91. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern

92. Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (Covishield™) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021

93. First case of Zika virus infection during an outbreak of chikungunya in a rural region of Maharashtra state, India

95. Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against Alpha, Beta, Delta and Omicron variants of concern

97. Detection and isolation of SARS‐CoV‐2 Eta variant from the international travelers and local residents of India

98. Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine

100. Additional file 2 of A case control investigation of COVID-19 associated mucormycosis in India

Catalog

Books, media, physical & digital resources